Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024 “alfapump implantation significantly improved quality of life and showed similar safety...
PRESS RELEASE: REGULATED INFORMATION “ INSIDE INFORMATION 22 MAY 2024, 07:00 CEST Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump® ...
PRESS RELEASEREGULATED INFORMATION23 April 2024, 07:00 am CET Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024 Publication of Annual Report 2023...
PRESS RELEASEREGULATED INFORMATION “ INSIDE INFORMATION28 March 2024, 08:00 a.m. CET alfapump® “ PMA1 submitted to US FDA and accepted for substantive review, extensive feedback just received from...